Vitamin B12 Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Pharmaceutical, Animal Feed, Food & Beverages, Healthcare, Personal Care, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 169.46 Million
CAGR (2026-2031)	2.88%
Fastest Growing Segment	Direct
Largest Market	North America
Market Size (2031)	USD 200.93 Million

Market Overview

The Global Vitamin B12 Market is projected to grow from USD 169.46 Million in 2025 to USD 200.93 Million by 2031 at a 2.88% CAGR. Vitamin B12, also known as cobalamin, is an essential water-soluble vitamin vital for neurological function, red blood cell formation, and DNA synthesis. The market's growth is fundamentally supported by increasing global awareness of vitamin deficiencies, the expanding adoption of vegetarian and vegan diets, and an aging global demographic. According to the Food and Agriculture Organization (FAO), by 2030, one in six people worldwide will be aged 60 or older, indicating a significant demographic shift that elevates the demand for B12 supplementation due to age-related malabsorption.

A significant challenge that could impede market expansion remains the complex and often protracted regulatory approval processes required for novel Vitamin B12 formulations and applications, which can increase development costs and extend market entry timelines.

Key Market Drivers

Prevalence of vitamin B12 deficiency
The high prevalence of vitamin B12 deficiency stands as a primary driver of growth in the global vitamin B12 market. This deficiency is a widespread health concern, particularly in regions with limited access to nutrient-rich foods or among specific dietary groups. The essential role of vitamin B12 in neurological function and red blood cell formation means that inadequate intake can lead to serious health implications, prompting a greater demand for supplementation and fortified food products. For instance, according to a study published in Frontiers in Nutrition in January 2026, hospitalizations associated with vitamin B12 deficiency in Brazil increased by 32% over the study period from 2016 to 2023, underscoring the significant health burden and the subsequent need for intervention.

Aging population and market dynamics
Concurrently, the rising global geriatric population substantially contributes to market expansion. Older adults are particularly susceptible to vitamin B12 malabsorption due to age-related changes in digestive function, necessitating regular supplementation to maintain adequate levels. According to the World Health Organization, in February 2025, the number of people aged 60 and older worldwide was projected to increase from 1.1 billion in 2023, highlighting a growing demographic requiring focused nutritional support. This demographic shift, coupled with an expanding understanding of vitamin B12's health benefits, stimulates demand across pharmaceutical and nutraceutical applications. Reinforcing the dynamic market landscape, Lonza, a prominent life sciences company, announced in March 2026 the divestment of its Capsules & Health Ingredients business to Lone Star Funds for $3 billion, reflecting significant strategic activity within the broader health ingredients sector where vitamin B12 plays a crucial role.

Download Free Sample Report

Key Market Challenges

The complex and often protracted regulatory approval processes for novel Vitamin B12 formulations and applications present a significant impediment to market expansion. These extensive procedures necessitate considerable financial investment in research, comprehensive clinical trials, and meticulous documentation, thereby substantially inflating overall development costs. Delays in securing necessary approvals consequently extend timelines for market entry, diminishing the window for companies to realize a return on investment and hindering further innovation. This substantial regulatory burden often discourages smaller enterprises and startups from undertaking the development of advanced B12 products, thereby restricting market diversification and the broader availability of novel solutions for consumers. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2025, the development of a new medicinal product from initial synthesis to market approval typically spans 12-13 years, with research and development costs estimated at €3,130 million. Such prolonged and costly processes directly challenge the timely introduction of beneficial Vitamin B12 advancements, thereby slowing market responsiveness to evolving health needs.

Key Market Trends

Technological advancements in Vitamin B12 supplement delivery represent a pivotal trend shaping the global market. Innovations focus on enhancing bioavailability and consumer convenience through novel formulations. For instance, sublingual tablets, oral sprays, and fast-dissolving strips are gaining traction due to their improved absorption profiles and ease of use compared to traditional oral capsules. These advanced methods cater to diverse demographics, including those with malabsorption issues or difficulty swallowing. According to Feed Ingredients, April 2026, in the "Vitamin B12 Market 2026: Applications, Buyers & Supply Chain Insights" article, EUROAPI committed US$ 43.3 million to upgrade its Vitamin B12 manufacturing facility in March 2026, aiming to boost output and sustainability. This investment underscores the industry's commitment to optimizing production and delivery.

Concurrently, the expansion of e-commerce and online distribution channels is significantly influencing the accessibility and reach of Vitamin B12 products. Digital platforms offer consumers a wide array of choices, detailed product information, and the convenience of direct home delivery, thereby expanding the market beyond traditional retail spaces. This shift facilitates easier access for a broader consumer base, including those in remote areas or with limited mobility. According to Pharmacy Practice, October 2025, in the "E-Commerce and the Vitamins and Supplements Market: Considerations for Pharmacy Practice" article, worldwide sales of nutritional supplements are forecast to surpass $200 billion by 2027, with online sales projected to be among the industry's top-growing segments. This highlights the increasing prominence of digital channels in the distribution landscape.

Segmental Insights

The Direct segment is experiencing rapid growth within the Global Vitamin B12 Market, primarily driven by the expansion of e-commerce platforms and online pharmacies that enhance accessibility for consumers. This growth is further propelled by the increasing demand for convenient and health-enhancing products, including innovative direct administration methods such as sublingual tablets and oral sprays that offer improved absorption and user-friendliness. Additionally, a heightened consumer awareness of the health benefits of over-the-counter vitamin B12, coupled with effective online education and targeted marketing strategies, contributes significantly to the escalating adoption of direct purchasing channels for these supplements.

Regional Insights

North America stands as the leading region in the Global Vitamin B12 Market, primarily due to robust consumer awareness concerning the health benefits associated with vitamin B12. Elevated disposable incomes across the region facilitate greater consumer spending on health and wellness products, including dietary supplements and fortified foods. Favorable regulatory environments, exemplified by the U.S. Food and Drug Administration's less stringent regulations regarding B12 fortification, enable broader incorporation into various food items. This, alongside proactive health professional recommendations and widespread media outreach, solidly underpins the region's market leadership.

Recent Developments

• In May 2026, breakthrough research unveiled a sustainable method for producing biologically active vitamin B12 using a modified form of Spirulina. Scientists, leveraging a biotechnology system developed by VAXA Technologies in Iceland, cultivated Spirulina under precisely controlled light conditions in photobioreactors. This process enabled the algae to produce active vitamin B12 at levels comparable to those found in beef, offering a plant-based alternative to traditional animal sources. This innovation presents a significant advancement for the global Vitamin B12 market, particularly for addressing nutritional deficiencies in a more environmentally conscious manner.
• In April 2026, Triquetra Health introduced its BioActive B-Complex™ Liquid, marking a new product launch in the dietary supplement sector. This innovative liquid formula features five active B-vitamin form upgrades, notably including Tri-Form B12. The product is designed to deliver all B-vitamins in their active, methylated, or coenzyme forms, providing a comprehensive system for enhanced nutrient absorption. This launch targets consumers within the global Vitamin B12 market seeking highly bioavailable and readily usable B-vitamin complexes, addressing the challenges of nutrient conversion often associated with conventional supplements.
• In April 2026, Evonik announced a strategic investment of approximately €80 million to enhance its biotechnology capabilities at the Fermas site in Slovenská Ľupča, Slovakia. This investment specifically targets the expansion of advanced downstream fermentation technology to bolster the company's contract manufacturing services for drug substances. The expansion is projected to create around 50 new jobs at the facility. This move underscores Evonik's commitment to meeting the growing global demand for complex pharmaceutical ingredients, including those produced through fermentation, which are crucial to the global Vitamin B12 market.
• In February 2025, HealthTech BioActives (HTBA) completed a significant investment of €25 million to modernize its research, development, and manufacturing facility located in Murcia, Spain. This initiative culminated in the inauguration of a new production plant, establishing HTBA as the sole company in Europe capable of producing all active forms of vitamin B12. The investment reinforced the company's global leadership in the production of active forms of vitamin B12 and citrus flavonoids, demonstrating a commitment to high-quality and environmentally responsible manufacturing practices within the global Vitamin B12 market.

Key Market Players

• BASF SE
• Lonza Group AG
• Sanofi S.A.
• Pfizer Inc.
• Merck KGaA
• Teva Pharmaceutical Industries Ltd.
• Dr. Reddy’s Laboratories Ltd.
• Intas Pharmaceuticals Ltd.
• Mylan N.V.
• Now Health Group Inc.

By Sales Channel	By End Use	By Region
Direct Indirect	Pharmaceutical Animal Feed Food & Beverages Healthcare Personal Care Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Vitamin B12 Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vitamin B12 Market, By Sales Channel:

• Direct
• Indirect

• Vitamin B12 Market, By End Use:

• Pharmaceutical
• Animal Feed
• Food & Beverages
• Healthcare
• Personal Care
• Others

• Vitamin B12 Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE